推荐产品
质量水平
方案
97%
表单
powder
mp
188-191 °C (dec.) (lit.)
溶解性
water: soluble 25 mg/mL, clear, colorless
SMILES字符串
Nc1nncs1
InChI
1S/C2H3N3S/c3-2-5-4-1-6-2/h1H,(H2,3,5)
InChI key
QUKGLNCXGVWCJX-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
2-氨基-1,3,4-噻二唑(供体)与 2,3-二氯-5,6-二氰--p -苯醌、-p -氯醌、-o -氯醌、-p -溴苯腈和氯苯胺酸(受体)形成电荷转移络合物 。2-氨基-1,3,4-噻二唑 [氨基噻二唑 (NSC 4728)] 对体内 L1210 腹水细胞 的嘌呤和嘧啶核苷酸池的影响 已有报道 。
警示用语:
Warning
危险分类
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
历史批次信息供参考:
American journal of clinical oncology, 19(4), 400-402 (1996-08-01)
Aminothiadiazole (NSC 4728) is an analog of the thiadiazoles, a group of drugs that stimulated interest because they do not cause significant myelosuppression and have a unique ability to increase uric acid production unrelated to tissue damage. Previous articles have
Bioelectrochemistry (Amsterdam, Netherlands), 79(2), 168-172 (2010-04-23)
We report the selective determination of homocysteine (HCY) in the presence of one of the very important interferents, ascorbic acid (AA) using electropolymerized film of 2-amino-1,3,4-thiadiazole (ATD) modified glassy carbon electrode (GCE) at physiological pH for the first time. An
American journal of clinical oncology, 9(4), 334-336 (1986-08-01)
Thirty-two evaluable patients with advanced epithelial ovarian cancer were treated with aminothiadiazole at a dosage of 125 mg/m2 weekly. Two patients had partial responses, 12 had stable disease, 16 had increasing disease, and two were inevaluable for response. Aminothiadiazole used
PloS one, 8(1), e54595-e54595 (2013-01-29)
Hepatocellular carcinoma (HCC) is the third most common cause of cancer fatalities worldwide, with limited treatment options and five year survival rates of between <5 and 15%. To address this medical need, we conducted a screen of a drug-like small
American journal of clinical oncology, 14(1), 33-35 (1991-02-01)
Twenty-three patients with advanced inoperable squamous cell carcinoma of the esophagus were treated with aminothiadiazole (A-TD) 125 mg/m2 weekly plus allopurinol daily in a phase II cooperative group trial. No patients responded to treatment; 17 patients progressed, three showed stable
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门